Physicians

This guide provides information for understanding a program’s epidemiology, determining if and when an outbreak might be occurring, and when additional resources and activities might be needed.

This monograph describes 10 steps in the diagnosis, management, and prevention of Syphilis.

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events. The medication tracker includes space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

This material was developed for clinicians to use with patients that are prescribed the three months of daily isoniazid plus rifampin (3HR) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 3HR regimen.

Speakers for this webinar include the Deputy Director of the Global TB Institute and a survivor of MDR-TB. By the end of the webinar, participants will be able to: define stigma in the context of tuberculosis prevention and care, describe how stigma affects persons with tuberculosis, and apply interventions in the health care setting and community to reduce stigma.

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

This video presents information on the difference between TB infection and disease, testing methods and recommendations, and interpretation of test results. The video also discusses special considerations for testing and the medical evaluation process.

The video contains information on the basics of TB infection, targeted testing, recommendations for screening and testing high-risk groups, and patient education messages.

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

This pocket card provides information on the treatment of drug-susceptible TB disease. The pocket card is adapted from the 2016 Official American Thoracic Society, Centers for Disease Control and Prevention, Infectious Disease Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.